SSY — SunLink Health Systems Income Statement
0.000.00%
Last trade - 00:00
- $4.84m
- $2.79m
- $47.95m
- 77
- 82
- 26
- 65
2019 June 30th | 2020 June 30th | 2021 June 30th | 2022 June 30th | 2023 June 30th | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 45.6 | 47.8 | 40.7 | 41.3 | 47.9 |
Cost of Revenue | |||||
Gross Profit | 26.7 | 28.8 | 25.1 | 24.9 | 29.4 |
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 47.9 | 48.3 | 33.7 | 43 | 49.8 |
Operating Profit | -2.29 | -0.453 | 7.01 | -1.61 | -1.81 |
Total Net Non Operating Interest Income / Expense | |||||
Gain / Loss on Sale of Assets | |||||
Total Net Non Operating Interest Income / Expense | |||||
Net Income Before Taxes | -2.08 | -0.29 | 7 | -1.61 | -1.66 |
Provision for Income Taxes | |||||
Net Income After Taxes | -2 | -0.586 | 6.94 | -1.72 | -1.66 |
Net Income Before Extraordinary Items | |||||
Extraordinary Items | |||||
Net Income | -1.75 | -1.14 | 6.89 | -2.01 | -1.79 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -1.75 | -1.14 | 6.89 | -2.01 | -1.79 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -0.311 | -0.091 | 0.261 | -0.598 | -0.286 |